Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1009-1015

  Bergendal, A ^a,d   Linden A ^a   Skoogh, B E ^a   Gerspacher, M ^c   Anderson, G P ^c   Lofdahl C G ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c CIBA GEIGY LTD   (Switzerland)

^d Lung Pharmacology Group   (Sweden)

Author keywords

Airway smooth muscle relaxation; Duration of action; Exosite; Reassertion; Salmeterol; Salmeterol analogues; adrenoceptor agonists

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ALIPHATIC CARBOXYLIC ACID; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LIPID; SALMETEROL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG CONFORMATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; GUINEA PIG; LIPID MEMBRANE; LIPOPHILICITY; MOLECULAR MODEL; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; STRUCTURE ACTIVITY RELATION; TRACHEA MUSCLE;

EID: 0029926249     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16690.x     Document Type: Article

References (21)

1. ANDERSON, G.P., LINDÉN, A. & RABE, K.F. (1994). Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J., 7, 569-578.
2. BALL, D.I., BRITTAIN, R.T., COLEMAN, R.A., DENYER, L.H., JACK, D., JOHNSON, M., LUNTS, L.H.C., NIALS, A.T., SHELDRICK, K.E. & SKIDMORE, I.F. (1991). Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmacol., 104, 665-671.
3. BERGENDAL, A., LINDÉN, A., LÖTVALL, J., SKOOGH, B.-E. & LÖFDAHL, C.-G. (1995a). Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea. Br. J. Pharmacol., 114, 1478-1482.
4. BERGENDAL, A., LINDEN, A., SKOOGH, B.-E. & LÖFDAHL, C.-G. (1995b). Three different salmeterol-related compounds could not alter the reassertion effect of salmeterol in the guinea-pig trachea. Am. J. Respir. Crit. Care Med., 151, A272.
5. BRITTAIN, R.T. (1990). Approaches to a long-acting, selective beta 2-adrenoceptor stimulant. Lung., 168 (suppl.), 111-114.
6. COLLINS, D.T., HARTLEY, D., JACK, D., LUNTS, L.H.C., PRESS, J.C., RITCHIE, A.C. & TOON, P. (1970). Saligenin analogues of sympathomimetic catecholamines. J. Med. Chem., 13, 674-680.
7. 2-adrenoceptor agonist salmeterol in guinea-pig trachea. Br. J. Pharmacol., 104, 1057-1061.
8. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur. J. Pharmacol., 206, 133-138.
9. JEPPSSON, A.-B., LÖFDAHL, C.-G., WALDECK, B. & WIDMARK, E. (1989). On the predictive value of in vitro experiments in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulm. Pharmacol., 2, 81-85.
10. oct from structures. Chem. Rev., 93, 1281-1306.
11. LEWELL, X.Q. (1992). A model of the adrenergic β2-receptor and binding sites for agonist and antagonist. Drug Design Disc., 9, 29-48.
12. LINDÉN, A., BERGENDAL, A., ULLMAN, A., SKOOGH, B.-E. & LÖFDAHL, C.-G. (1991). High concentration of formoterol and salmeterol in the isolated guinea-pig trachea Reassertion of smooth muscle relaxation after beta blockade followed by wash-out. Am. J. Respir. Dis., 143 (4S), A749.
13. LINDÉN, A., BERGENDAL, A., ULLMAN, A., SKOOGH, B.-E. & LÖFDAHL, C.-G. (1993). Salmeterol and formoterol compared to salbutamol in isolated airways: Differences in efficacy and potency but not in functional antagonism. Thorax, 48, 547-53.
14. LÖTVALL, J., LUNDE, H., HEDNER, J. & SVEDMYR, N. (1994). Onset of bronchodilation and tremor inducing effect of salmeterol and salbutamol (albuterol) up to two hours after inhalation. Am. J. Respir. Crit. Care Med., 149 (4 suppl), A206.
15. MOHAMADI, F., RICHARDS, N.G.L. & GUIDA, W.C. (1990). Macromodel. J. Comp. Chem., 11, 440.
16. NIALS, A.T., SUMNER, M.J., JOHNSON, M. & COLEMAN, R.A., (1993). Investigations into factors determining the duration of action of the β2-adrenoceptor agonist, salmeterol. Br. J. Pharmacol., 108, 507-515.
17. PEARLMAN, D.S., CHERVINSKY, P., LAFORCE, C., SELTZER, J.M., SOUTHERN, D.L., KEMP, J.P., DOCKHORN, R.J., GROSSMAN, J., LIDDLE, R.F., YANCEY, S.W., COCCHETTO, D.M., ALEXANDER, W.J. & VAN AS, A. (1992). A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N. Engl. J. Med., 327, 1420-1425.
18. SANDSTRÖM, T., FREDRIKSEN, B., ROSENHALL, L. & SANDSTRÖM, B. (1989). Salmeterol a dose response study with a long acting inhaled β2-agonist. Am. Rev. Respir. Dis., 139 (suppl), A64.
19. ULLMAN, A., BERGENDAL, A., LINDÉN, A., WALDECK, B., SKOOGH, B.-E. & LÖFDAHL, C.-G. (1992). Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea-pig trachea with and without epithelium. Allergy, 47, 384-387.
20. ULLMAN, A. & SVEDMYR, N. (1988). Salmeterol, a new long acting inhaled β2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax, 43, 674-678.
21. VOSS, H.-P. (1994). Long-acting β2-adrenoceptor agonists in asthma: molecular pharmacological aspects. Thesis, Vrije Universiteit, Amsterdam, The Netherlands.